GAINESVILLE, Fla., July 27, 2010 (GLOBE NEWSWIRE) -- Quick-Med Technologies, Inc. (OTCBB:QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, has recently launched a new website, www.quickmedtech.com, highlighting its innovative patented technologies.
"This website is designed to deliver relevant corporate information on Quick-Med to our partners, investors and scientific community, in the most efficient manner possible," said J. Ladd Greeno, Quick-Med's CEO. "Its intuitive layout offers easy-to-navigate pages that showcase our presence in the antimicrobial market. We also invite individuals to sign up for the email alerts when they visit the site, to stay on top of our most recent developments."
The launch of the new website reinforces Quick-Med's commitment to provide detailed information of its four core technologies through published scientific papers, poster presentations, and company news releases. The website includes the following sections: about us, technology, business development, news releases, publications and investor relations.
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc is a life sciences company focused on developing proprietary, broad-based technologies for infection prevention and control in the consumer and healthcare markets. Quick-Med commercialized its NIMBUS technology in traditional wound care products in 2009 and is developing NIMBUS applications in several other advanced wound dressing formats including adhesives, foams, hydrogels, films, and hydrocolloids. For more information, see: www.quickmedtech.com.
© 2010 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® is a registered trademark of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.